Weijing Gong

702 total citations
25 papers, 556 citations indexed

About

Weijing Gong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weijing Gong has authored 25 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weijing Gong's work include Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Weijing Gong is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Weijing Gong collaborates with scholars based in China, United States and Australia. Weijing Gong's co-authors include Zhaoqian Liu, Ji‐Ye Yin, Di Xiao, Hong‐Hao Zhou, Wei Zhang, Xi Li, Chao Fang, Xiangping Li, Hong‐Hao Zhou and Sanlan Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Weijing Gong

25 papers receiving 550 citations

Peers

Weijing Gong
Ping Song China
Weijing Gong
Citations per year, relative to Weijing Gong Weijing Gong (= 1×) peers Ping Song

Countries citing papers authored by Weijing Gong

Since Specialization
Citations

This map shows the geographic impact of Weijing Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijing Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijing Gong more than expected).

Fields of papers citing papers by Weijing Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijing Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijing Gong. The network helps show where Weijing Gong may publish in the future.

Co-authorship network of co-authors of Weijing Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Weijing Gong. A scholar is included among the top collaborators of Weijing Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijing Gong. Weijing Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Chao, Tian Wang, Sanlan Wu, et al.. (2024). Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study. BMC Pulmonary Medicine. 24(1). 167–167. 1 indexed citations
3.
Mei, Chao, Weijing Gong, Xu Wang, et al.. (2023). Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine. Frontiers in Pharmacology. 14. 1147717–1147717. 17 indexed citations
4.
Xu, Chenfeng, Fang Zeng, Qiling Xu, et al.. (2023). Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 63(1). 107021–107021. 14 indexed citations
5.
Wu, Sanlan, Weijing Gong, Peng Cao, et al.. (2022). Application of Population Pharmacokinetic Analysis to Characterize CYP2C19 Mediated Metabolic Mechanism of Voriconazole and Support Dose Optimization. Frontiers in Pharmacology. 12. 730826–730826. 7 indexed citations
6.
Shi, Chen, Jinmei Liu, Jianli Hu, et al.. (2022). Genetic and Clinical Factors Associated with Opioid Response in Chinese Han Patients with Cancer Pain: An Exploratory Cross-Sectional Study. Pain and Therapy. 11(1). 269–288. 4 indexed citations
7.
Gong, Weijing, Peng Cao, Qilin Zhang, et al.. (2022). Prediction of response and adverse drug reaction of pemetrexed plus platinum-based chemotherapy in lung adenocarcinoma by serum metabolomic profiling. Translational Oncology. 19. 101393–101393. 3 indexed citations
9.
Gong, Weijing, Tao Zhou, Sanlan Wu, et al.. (2021). A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19. Journal of Infection and Chemotherapy. 27(6). 876–881. 27 indexed citations
10.
Gong, Weijing, Tao Zhou, Sanlan Wu, et al.. (2021). A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma. Annals of Translational Medicine. 9(18). 1484–1484. 8 indexed citations
11.
Gong, Weijing, Tao Zhou, Liping Xiang, et al.. (2021). Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway. Medical Oncology. 38(6). 65–65. 3 indexed citations
12.
Chen, Shuangye, et al.. (2021). Research on Vision Control System of Pipeline Robot. 2021 China Automation Congress (CAC). 1 indexed citations
13.
Gong, Weijing, Liyun Ma, Hu Lei, et al.. (2019). STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy. International Journal of Clinical Oncology. 24(5). 476–484. 13 indexed citations
14.
Gong, Weijing, Junyan Liu, Ji‐Ye Yin, et al.. (2018). Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway. Cancer Science. 109(8). 2391–2400. 39 indexed citations
15.
Cui, Jiajia, Lei‐Yun Wang, Tao Zhu, et al.. (2017). Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients. Scientific Reports. 7(1). 5082–5082. 27 indexed citations
16.
Gong, Weijing, Ji‐Ye Yin, Xiangping Li, et al.. (2016). Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumor Biology. 37(6). 8349–8358. 150 indexed citations
17.
Li, Xiangping, Ji‐Ye Yin, Ying Wang, et al.. (2014). The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients. Tumor Biology. 35(8). 8259–8265. 17 indexed citations
18.
Xiao, Di, Weijing Gong, Huixia Liu, et al.. (2014). JAZF1 can regulate the expression of lipid metabolic genes and inhibit lipid accumulation in adipocytes. Biochemical and Biophysical Research Communications. 445(3). 673–680. 28 indexed citations
20.
OBIKAWA, Toshiyuki, et al.. (1996). Tool wear monitoring for optimizing cutting conditions. Journal of Materials Processing Technology. 62(4). 374–379. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026